Correlation between p53 mutations and antibody staining in breast carcinoma
β Scribed by Miss J. M. Dunn; D. J. Hastrich; P. Newcomb; J. C. J. Webb; N. J. Maitland; J. R. Farndon
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 383 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Only half of colorectal-cancer patients elicit serum antibodies in response to intratumoral p53-gene mutations. Our study was designed to compare cellular events (p53-protein accumulation and gene mutations) with the presence of circulating anti-p53 antibodies (p53-Ab). Thirty-five colorectalcancer
A discordance between p53 protein overexpression and the presence of mutations in the gene has been observed in many types of tumors, including human lymphomas. To probe this finding, we have studied a large series of 94 lymphomas of different pathologic types and histologic differentiation. Analyzi
## Esophageal cancer (EC) in the Indian population presents in advanced stages with poor prognosis and warrants the identification of a non-invasive marker for early detection and better prognostic assessment. We have previously reported high prevalence of p53 protein accumulation in esophageal squ
## Background: P53 gene mutation and p53 protein accumulation are common in human cancer. however, their clinical significance is controversial and p53 accumulation may not correlate with gene mutation. the current study investigates the occurrence of p53 alterations in esophageal carcinoma, the co
The cyclin-dependent kinase inhibitor p21/WAF1 is regulated by p53-dependent and p53-independent pathways. In addition, p21/WAF1 binds with proliferating cell nuclear antigen (PCNA) and inhibits the action of PCNA. To investigate the possible role of p21/WAF1 in human hepatocellular carcinomas (HCCs